COMT and Parkinson disease: EGCG also inhibited the activity of catechol-O-methyltransferase (COMT) and in turn inhibited COMT catalysed methylation of endogenous and exogenous compounds, delivering a neuroprotective effect in both animal and cell models of PD [132].